Physiomics (PYC)

 

PYC Share PerformanceMore

52 week high2.4000 22/12/16
52 week low0.9190 26/10/17
52 week change -1.2750 (-56.67%)
4 week volume7,673,001 27/10/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Dispatch of Annual Report and Shareholder Circular

RNS Number: 7186V Physiomics PLC 09 November 2017 9 th November 2017 Physiomics plc ("Physiomics") or ("the Company") Dispatch of Annual Report and Shareholder Circular Dispatch of Documentation Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has published and posted to shareholders - its An...

Physiomics annual loss widens

Physiomics said its annual losses deepened after second-half revenue and profits came in below its expectations. The compa...

Final Results

RNS Number: 6079T Physiomics PLC 16 October 2017 16 October 2017 Physiomics Plc ("Physiomics" or "the Company") Final Results for the year ended 30 June 2017 Chairman's Statement Summary of Results in the year ended 30 June 2017 Total income (revenue and grant income) decreased 9% to 270,465 (2016: 297,120) The operating loss before exceptional costs incr...

Physiomics enters talks with potential large client

Physiomics said it has entered term sheet discussions with a potential major client that could secure a significant volume of...

Company Update

RNS Number: 3145S Physiomics PLC 02 October 2017 Physiomics plc ("Physiomics") or ("the Company") Company update Physiomics plc (AIM: PYC) is pleased to announce positive developments relating to its core oncology and simulation business and to provide commentary on potential business collaborations and progress in diversifying into the personalised med...

Physiomics seals new contracts

Physiomics signed two new contracts with a global pharma company for Virtual Tumour pre-clinical predictions relating...

Two New Pre-Clinical Contracts

RNS Number: 4987M Physiomics PLC 31 July 2017 Physiomics plc ("Physiomics") or ("the Company") Two new pre-clinical contracts Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has today signed two new contracts with a global pharma company for Virtual Tumour pre-clinical predictions relating to a n...

Physiomics to Attend PAGE 2017

RNS Number: 1956H Physiomics PLC 06 June 2017 Physiomics Plc ("Physiomics" or "the Company") Physiomics to attend PAGE 2017 Oxford, UK, 6 th June 2017: Physiomics is pleased to announce that it will attend the Population Approach Group Europe (PAGE) Annual Conference taking place in Budapest, Hungary 7-9 June. PAGE is Europe's premier conference ...

Fundamental DataMore

EPS-0.78
Dividend yield0 %

Latest discussion posts More

  • great news

    promising rns.Buy now and hold.gla
    2-Oct-2017
    etadelete
  • Nothing great!

    Just peace meal work.. Nothing revolutionary!
    31-Jul-2017
    clockwurktangerine
  • Re: Two small fees

    Why?
    25-May-2017
    clockwurktangerine

Users' HoldingsMore

Users who hold Physiomics also hold..
SAREUM21%
SOLO OIL20%
RANGE RES.18%
LLOYDS GRP.18%
VALIRX16%

Codes & Symbols

ISINGB00BDR6W943
SymbolsPYC, LSE:PYC, PYC.L, PYC:LN, LON:PYC, XLON:PYC

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account